Earnings Feed
Start Free
Home/Filings/4/0001209191-17-003660
4//SEC Filing

VERTEX PHARMACEUTICALS INC / MA 4

Accession 0001209191-17-003660

$VRTXCIK 0000875320operating
View on SEC.govCompany Profile

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 4:12 PM ET

Size

17.4 KB

Accession

0001209191-17-003660

Insider Transaction Report

Form 4
Period: 2017-01-11
VERTEX PHARMACEUTICALS INC / MAVRTX
BOGER JOSHUA S
DirectorCEO
Transactions
  • Exercise/Conversion

    Common Stock

    2017-01-11$36.30/sh+8,000$290,400→ 276,225 total
  • Sale

    Common Stock

    2017-01-11$81.25/sh−2,400$195,000→ 273,825 total
  • Sale

    Common Stock

    2017-01-11$82.92/sh−1,100$91,212→ 269,825 total
  • Sale

    Common Stock

    2017-01-11$82.17/sh−2,900$238,293→ 270,925 total
  • Sale

    Common Stock

    2017-01-11$84.41/sh−1,100$92,851→ 268,725 total
  • Sale

    Common Stock

    2017-01-11$84.98/sh−500$42,490→ 268,225 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-01-11−8,000→ 0 total
    Exercise: $36.30Exp: 2017-01-23→ Common Stock (8,000 underlying)
Holdings

  • Common Stock

    (indirect: By 401(k))
    13,286

  • Common Stock

    (indirect: By Trust)
    78,200
Footnotes (8)
  • [F1]Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
  • [F2]Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  • [F3]Open market sales reported on this line occurred at a weighted average price of $81.25 (range $80.61 to $81.60).
  • [F4]Open market sales reported on this line occurred at a weighted average price of $82.17 (range $81.62 to $82.55).
  • [F5]Open market sales reported on this line occurred at a weighted average price of $82.92 (range $82.64 to $83.24).
  • [F6]Open market sales reported on this line occurred at a weighted average price of $84.41 (range $83.72 to $84.70).
  • [F7]Open market sales reported on this line occurred at a weighted average price of $84.98 (range $84.87 to $85.11).
  • [F8]Fully vested.

Documents

1 file

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

→
Entity typeoperating
IncorporatedMA

Related Parties

1
  • filerCIK 0000875320

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:12 PM ET
Size
17.4 KB
View on SEC.gov